Tagpre-exposure prophylaxis (PrEP)

Men who have Sex with Men and Chemsex: A Clinic-Based Cross-sectional Study in South Australia

M

Khaw, C., Zablotska-Manos, I. & Boyd, M.A. Sex Res Soc Policy (2020). Abstract: Background Chemsex, the intentional combining of sex with the use of particular psychoactive substances typically crystal methamphetamine, gamma-hydroxybutyrate(GHB)/gamma butyrolactone(GBL), mephedrone, and ketamine has been reported among men who have sex with men (MSM). Chemsex is more common among MSM than in...

Trans and cis women and men all have similar levels of PrEP drugs in blood

T

nam/aidsmap, 7 September 2020 A study in which 24 trans women and 24 trans men who were taking gender-affirming hormone therapy were directly observed to take a daily dose of the standard formulation of the HIV prevention medication PrEP found that the levels of the two PrEP drugs tenofovir and emtricitabine were similar to the levels seen in similar cis men and women, and were all above levels...

Flux Study COVID-19 Diary Recruitment and Report

F

Kirby Institute, UNSW, July 2020 Social distancing restrictions due to COVID-19 may affect how gay and bisexual men are arranging their sex lives and taking care of their health. And this will likely also affect trends in HIV infection and STIs over coming months, or even years. Monitoring the impact of COVID-19, before, during, and after the pandemic, is essential to understanding and responding...

Marie Stopes Australia seeks signatories to open letter re changes to telehealth

M

July 2020   There are changes to Telehealth from Monday, July 20th which mean that clients who have not attended a service within the last 12 months – that is, new clients or clients who have not used a service in the last 12 months – will no longer be eligible for a Telehealth appointment.   Marie Stopes Australia has written an open letter about the impact of this change access to...

Information about TRUVADA and ATRIPLA delisting

I

Australian Federation of AIDS Organisations (AFAO), March 30th 2020 From 1 April 2020 Truvada for HIV treatment and for pre-exposure prophylaxis (PrEP) will no longer be available through the Pharmaceutical Benefits Scheme (PBS). There are alternatives to Truvada for PrEP in Australia. Community members eligible for PrEP can access generic versions of Truvada supplied by Apotex, Mylan and Lupin...

Increased usage and confidence in antiretroviral PrEP for the prevention of HIV found in UNSW study

I

UNSW, December 2019 The number of gay and bisexual men using PrEP to prevent HIV infection has almost doubled in the last two years, according to the latest report from the PrEPARE Project.   The national online survey of Australian gay and bisexual men found that 43% of gay and bisexual men had used the antiretroviral drug in 2019, up from 24% in 2017. This increase aligns with falling HIV...

Your sidebar area is currently empty. Hurry up and add some widgets.